Product news from the 04/14/06 News Brief

Share this article:
FDA approved Alkermes and Cephalon’s Vivitrol (naltrexone for extended-release injectable suspension) for the treatment of alcohol dependence. The FDA has granted final approval to Dr. Reddy’s Laboratories’ Abbreviated New Drug Application for fexofenadine hydrochloride tablets, 30 mg, 60 mg and 180 mg. Fexofenadine hydrochloride is the generic equivalent of Sanofi-Aventis’ allergy drug Allegra. Dr. Reddy’s said it will begin the commercial marketing of this product immediately. Roche has filed for US approval of an expanded lung cancer indication for its Avastin colorectal cancer drug. Roche said studies show that Avastin is beneficial to patients with nonsquamous non-small-cell lung cancer, which accounts for 87% of all lung cancer cases in the US.
Share this article:

Email Newsletters

More in Business Briefs

Social media perceived as clinical trial risk

The Wall Street Journal reports that patients are sharing a plethora of information about their clinical trial experiences, from how to get picked, to how to figure out who is in a control group.

Cancer PSA features scientists

Stand Up To Cancer is kicking off a PSA that features Grammy-winner Jennifer Hudson and a Genentech scientist.

Lawmakers eye pricing

The Senate Judiciary Committee's antitrust panel is looking into how three major pharmaceutical manufacturers decided to set minimum prices for their contact lenses.